These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 7878261

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.
    Hanly JG, Thompson K, McCurdy G, Fougere L, Theriault C, Wilton K.
    J Immunol Methods; 2010 Jan 31; 352(1-2):147-52. PubMed ID: 19836394
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
    Hoffman IE, Lauwerys BR, De Keyser F, Huizinga TW, Isenberg D, Cebecauer L, Dehoorne J, Joos R, Hendrickx G, Houssiau F, Elewaut D.
    Ann Rheum Dis; 2009 Mar 31; 68(3):412-5. PubMed ID: 18930995
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
    Půtová I, Dostal C, Becvar R.
    Ann N Y Acad Sci; 2007 Aug 31; 1109():275-86. PubMed ID: 17785316
    [Abstract] [Full Text] [Related]

  • 7. Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus.
    Haddouk S, Marzouk S, Jallouli M, Fourati H, Frigui M, Hmida YB, Koubaa F, Sellami W, Baklouti S, Hachicha J, Bahloul Z, Masmoudi H.
    Rheumatology (Oxford); 2009 Aug 31; 48(8):953-7. PubMed ID: 19502474
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Prognostic value of anti-RNP/Sm and anti-Ro/La antibodies in lupus nephropathy].
    López-Longo FJ, López-Gómez JM, Jofre Ibáñez R, Escalona M, Rodríguez-Mahou M.
    Rev Clin Esp; 1992 Nov 31; 191(7):354-9. PubMed ID: 1475460
    [Abstract] [Full Text] [Related]

  • 10. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P, Hermanová Z, Faltýnek L, Pospísil Z, Scudla V.
    Vnitr Lek; 1997 Oct 31; 43(10):639-44. PubMed ID: 9601876
    [Abstract] [Full Text] [Related]

  • 11. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct 31; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 12. A close temporal relationship of liver disease to antiribosomal P0 protein antibodies and central nervous system disease in patients with systemic lupus erythematosus.
    Yoshio T, Masuyama JI, Minota S, Kaneko N, Iwamoto M, Okazaki H, Mimori A, Takeda A, Kano S.
    J Rheumatol; 1998 Apr 31; 25(4):681-8. PubMed ID: 9558169
    [Abstract] [Full Text] [Related]

  • 13. Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus.
    Yoshio T, Masuyama J, Ikeda M, Tamai K, Hachiya T, Emori T, Mimori A, Takeda A, Minota S, Kano S.
    J Rheumatol; 1995 Sep 31; 22(9):1681-7. PubMed ID: 8523345
    [Abstract] [Full Text] [Related]

  • 14. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P.
    Scand J Rheumatol; 2007 Sep 31; 36(6):442-7. PubMed ID: 18092265
    [Abstract] [Full Text] [Related]

  • 15. Indirect immunofluorescence on HEp-2000 substrate is a sensitive method for detecting anti-Ro/SSA antibodies in patients with lupus erythematosus and/or photosensitivity.
    Cozzani E, Drosera M, Siccardi M, Babbini G, Parodi A.
    J Rheumatol; 2008 Jul 31; 35(7):1320-2. PubMed ID: 18528967
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of anti-ribosomal P protein immunoassay in Japanese patients with connective tissue diseases: comparison with an indirect immunofluorescence assay.
    Muro Y, Sugiura K, Morita Y, Tomita Y.
    Scand J Rheumatol; 2009 Jul 31; 38(6):460-3. PubMed ID: 19922022
    [Abstract] [Full Text] [Related]

  • 17. Anti-ribosomal-P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays.
    Agmon-Levin N, Gilburd B, Kivity S, Katz BS, Flitman-Katzevman I, Shoenfeld N, Paran D, Langevitz P, Shoenfeld Y.
    Isr Med Assoc J; 2009 Jul 31; 11(7):403-6. PubMed ID: 19911490
    [Abstract] [Full Text] [Related]

  • 18. Systemic lupus erythematosus associated with antiribosomal P protein antibody.
    Takehara K, Nojima Y, Kikuchi K, Igarashi A, Soma Y, Tsuchida T, Ishibashi Y.
    Arch Dermatol; 1990 Sep 31; 126(9):1184-6. PubMed ID: 2204307
    [Abstract] [Full Text] [Related]

  • 19. Characterization of ribosomal P autoantibodies in relation to cell destruction and autoimmune disease.
    Ersvaer E, Bertelsen LT, Espenes LC, Bredholt T, Bøe SO, Iversen BM, Bruserud Ø, Ulvestad E, Gjertsen BT.
    Scand J Immunol; 2004 Sep 31; 60(1-2):189-98. PubMed ID: 15238089
    [Abstract] [Full Text] [Related]

  • 20. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
    Yoshio T, Hirata D, Onda K, Nara H, Minota S.
    J Rheumatol; 2005 Jan 31; 32(1):34-9. PubMed ID: 15630721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.